E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy
Simone Claudiani,
Jane F. Apperley,
Robert Peter Gale,
Richard Clark,
Richard Szydlo,
Simona Deplano,
Renuka Palanicawandar,
Jamshid Khorashad,
Letizia Foroni,
Dragana Milojkovic
Affiliations
Simone Claudiani
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Jane F. Apperley
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Robert Peter Gale
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Richard Clark
Royal Liverpool University Hospital, UK
Richard Szydlo
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Simona Deplano
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Renuka Palanicawandar
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Jamshid Khorashad
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Letizia Foroni
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Dragana Milojkovic
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
